US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 27.020
  • +0.800+3.05%
Close Nov 22 16:00 ET
  • 27.020
  • 0.0000.00%
Post 20:01 ET
1.79BMarket Cap-10472P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 433.330K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 433.330K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--

Unlock Free Earnings Estimates

Celldex Therapeutics Earnings Reports

  • Celldex Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:07 ET

  • Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 6 16:02 ET

  • Celldex Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:57 ET

  • Celldex Therapeutics | 8-K: Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 8 16:49 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      81.82%

    • Hold

      18.18%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data